A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-Hodgkin's Lymphomas

Local Institution - 102, Marseille

Local Institution - 201, Milan

Local Institution - 202, Milan

Local Institution - 101, Dijon

Local Institution - 402, Madrid

Local Institution - 404, Madrid

Local Institution - 401, Santander

Local Institution - 200, Bologna

Local Institution - 100, Villejuif

Local Institution - 501, Chuo-ku

Local Institution - 502, Koto-Ku

Local Institution - 500, Kashiwa

Local Institution - 400, Barcelona

Local Institution - 300, London

Local Institution - 301, Newcastle upon Tyne